(redirected from Hypoglycemic agents)
Also found in: Dictionary, Thesaurus, Medical.


see diabetesdiabetes
or diabetes mellitus
, chronic disorder of glucose (sugar) metabolism caused by inadequate production or use of insulin, a hormone produced in specialized cells (beta cells in the islets of Langerhans) in the pancreas that allows the body to use and store
..... Click the link for more information.



a decrease in the sugar content of the blood to below 80-70 mg percent.

Hypoglycemia is found in healthy persons during heightened muscular activity as a result of the considerable expenditure of glucose as an energy source when the body’s energy loss is not replenished with readily assimilable carbohydrates. Hypoglycemia sometimes arises after heavy intake of carbohydrates as a result of the reflex secretion by the pancreas of an excessive amount of insulin. The condition is observed in certain diseases of the insular apparatus of the pancreas, the hypothalamic region of the brain, the other endocrine glands, or the liver (disruption of the liver’s function as the principal glycogen depot), as well as in insulin overdose (hypoglycemic shock). In hypoglycemic shock, after a short period of central nervous system excitation, a condition develops that is accompanied by weakness, drowsiness, hunger, and psychic disturbances. Trembling, loss of consciousness, and convulsions may set in when sugar content is lowered to 40 percent or less. The condition is eliminated by administering glucose. Hypoglycemic or insulin shock may be induced artificially for the treatment of certain diseases.


Genes, S. G. Gipoglikemiia: Gipoglikemiche skii simptomokompleks. Moscow, 1970. (Bibliography, pp. 224-35.)


Condition caused by low levels of sugar in the blood.
References in periodicals archive ?
We found little price sensitivity in the demand for oral hypoglycemic agents and statins among Part D beneficiaries with diabetes regardless of LIS support category.
Group B was started on multivitamin tablet as a placebo along with other hypoglycemic agents namely, metformin, acarbose, sulfonylureas, insulin therapy except pioglitazone.
Taken alone or concurrently with oral hypoglycemic agents with or without insulin Study Existing Length of medication follow-up Dans et al.
All patients were operated at oral and maxillofacial surgery unit of deMontmorency college of dentistry under general anesthesia with protocol shift of oral anti-diabetic drugs to systemic hypoglycemic agents.
Unlike GCK MODY, transcription factor MODY is characterized by hyperglycemia that progressively worsens and often requires treatment with oral hypoglycemic agents or insulin.
The drug was prescribed either as a monotherapy or in combination with other oral hypoglycemic agents or insulin.
We evaluated whether they had an altered risk of breast cancer in relation to use of various types of oral hypoglycemic agents.
Currently, there are six major classes of oral hypoglycemic agents available in the United States: agents that stimulate insulin secretion (sulfonylureas and rapid-acting secretagogues); reduce hepatic glucose production (biguanides); delay digestion and absorption of intestinal carbohydrates ([alpha]-glucosidase inhibitors); improve insulin action (thiazolidin-ediones [TZDs]); or inhibit glucagon release (dipeptidyl-peptidase 4 [DPP-4] inhibitors).
Gingko and garlic have increased the risk of bleeding with anticoagulants, while garlic has increased the hepatotoxicity of paracetamol and enhanced the effect of oral hypoglycemic agents.
The procedure maintained its effect through 3 years of follow-up, during which the patients significantly lowered their use of oral hypoglycemic agents and insulin.
They focus on providing an comprehensive scientific basis as they cover drug absorption and distribution, drug elimination, pharmacokinetics, drug action and interaction, variability in response, intravenous and inhaled anesthetic agents, local anesthetics, drugs that act on the neuromuscular junction, analgesics, pre-medication and anti-emetic drugs, the effects of drugs on the autonomic nervous system, antihypertensives, antiarrhythmic and antianginal drugs, antiplatelet and anticoagulant drugs, fibrinolytic agents, corticosteroids and hypoglycemic agents.